Scandinavian Biopharma Reports All-Time High Revenue for 2024

Scandinavian Biopharma is pleased to announce another year of strong growth, strategic milestones and key achievements. For the full year 2024, the company’s revenue reached 161 MSEK, reflecting continued momentum in both its distribution and development business. The company’s distribution business achieved its strongest sales performance to date, driven by the introduction of new products […]